Abstract

CD8 T cells protect the liver against viral infection, but can also cause severe liver damage that may even lead to organ failure. Given the lack of mechanistic insights and specific treatment options in patients with acute fulminant hepatitis, we develop a mouse model reflecting a severe acute virus-induced CD8 T cell-mediated hepatitis. Here we show that antigen-specific CD8 T cells induce liver damage in a perforin-dependent manner, yet liver failure is not caused by effector responses targeting virus-infected hepatocytes alone. Additionally, CD8 T cell mediated elimination of cross-presenting liver sinusoidal endothelial cells causes endothelial damage that leads to a dramatically impaired sinusoidal perfusion and indirectly to hepatocyte death. With the identification of perforin-mediated killing as a critical pathophysiologic mechanism of liver failure and the protective function of a new class of perforin inhibitor, our study opens new potential therapeutic angles for fulminant viral hepatitis.

Details

Title
Perforin inhibition protects from lethal endothelial damage during fulminant viral hepatitis
Author
Welz, M 1 ; Eickhoff, S 1 ; Abdullah, Z 1 ; Trebicka, J 2   VIAFID ORCID Logo  ; Gartlan, K H 3   VIAFID ORCID Logo  ; Spicer, J A 4 ; Demetris, A J 5 ; Akhlaghi, H 6 ; Anton, M 7 ; Manske, K 7 ; Zehn, D 8 ; Nieswandt, B 9 ; Kurts, C 1 ; Trapani, J A 6 ; Knolle, P 7 ; Wohlleber, D 7   VIAFID ORCID Logo  ; Kastenmüller, W 10   VIAFID ORCID Logo 

 Institute of Experimental Immunology, University Hospital, University of Bonn, Bonn, Germany 
 Department of Internal Medicine I, University of Bonn, Bonn, Germany; European Foundation for the Study of Chronic Liver Failure, Barcelona, Spain 
 QIMR Berghofer Medical Research Institute, Herston, Australia 
 Auckland Cancer Society Research Centre, University of Auckland, Auckland, New Zealand 
 Department of Pathology, University of Pittsburgh, Pittsburgh, PA, USA 
 Peter MacCallum Cancer Centre, Melbourne, VIC, Australia 
 Institute of Molecular Immunology and Experimental Oncology, Klinikum rechts der Isar, Technical University of Munich, München, Germany 
 Division of Animal Physiology and Immunology, School of Life Sciences Weihenstephan, Technical University of Munich, Freising, Germany 
 Institute of Experimental Biomedicine I, University of Wuerzburg, Wuerzburg, Germany 
10  Institute of Experimental Immunology, University Hospital, University of Bonn, Bonn, Germany; Institute of Systems Immunology, University of Wuerzburg, Wuerzburg, Germany 
Pages
1-13
Publication year
2018
Publication date
Nov 2018
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2133834786
Copyright
© 2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.